Evidence map›Paper›PMID 23391414›Full record

ReviewNucleic acid therapeutics2013

Long non-coding RNA targeting and transcriptional de-repression.

Marc S Weinberg, Kevin V Morris

Abstract readReview
In one paragraph

Review in Nucleic acid therapeutics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Silencing the expression of lncRNAAnnals of translational medicine · 2022
    Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 3 countries.

Marc S WeinbergDepartment of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California 92037, USA.
Kevin V Morris
Scripps Research Institute · USUniversity of the Witwatersrand · ZA

Funding

Targeted Delivery Vechicles for OligonucleotidesP01AI099783 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI AKKINA, RAMESH · 2012 to 2016
$7.4M
Activation of silenced tumor suppressor genes by non-coding RNAR01CA151574 · NCI · SCRIPPS RESEARCH INSTITUTE, THE · PI VOGT, PETER K · 2010 to 2014
$1.9M
The Antisense Transcriptome and the Epigenetics of Cancer.R01CA153124 · NCI · SCRIPPS RESEARCH INSTITUTE, THE · PI VOGT, PETER K · 2010 to 2013
$1.2M
ncRNA targeted excision of HIV-1 from human cellsR56AI096861 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI MORRIS, KEVIN V · 2011 to 2011
$474k
NCI NIH HHS R01 CA151574NCI NIH HHS R01 CA153124NIAID NIH HHS P01 AI099783-01NIAID NIH HHS R56 AI096861-01
6 · The paper itself

Abstract

Our current understanding of the molecular events that functionally characterize cellular biology continues to be revised. Recent observations find that the vast majority of the human genome is transcribed and may be functionally relevant. Many of these previously unrecognized transcripts, both short and long non-coding RNAs, have been found to be active modulators of protein coding gene function. While such observations were in the past relegated to imprinted genes, it is now becoming apparent that several different genes in differentiated cells may be under some form of non-coding RNA based regulatory control. Emerging evidence suggests that some of these long non-coding RNAs are functional in controlling gene transcription by the targeted recruitment of epigenetic silencing complexes to homology-containing loci in the genome. Most notably when these repressor non-coding RNAs are targeted using small RNA-based inhibitors (such as with RNA interference), a de-repression of the targeted gene can occur resulting in activation of gene expression. Knowledge of this emerging RNA based epigenetic regulatory network has implications not only in cellular evolution but also for the development of an entirely new area of pharmacology.

Indexed as

Transcription, GeneticEpigenesis, GeneticGene SilencingHumansModels, GeneticRNA, AntisenseRNA InterferenceRNA, Long NoncodingTranscriptional ActivationRNA, AntisenseRNA, Long Noncoding

Identifiers

PMID23391414
PMCPMC3569965
OpenAlexW2137034625

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.